BioSpace News Archive

Biologica Technologies, LLC (the “Company” or “Biologica”) announced today that they will be showcasing their latest clinical data for ProteiOS growth factor at this week’s Midwest Podiatry Conference held in Chicago, IL.

The American Board of Medical Specialties (ABMS), the leading organization that oversees the standards for physician Board Certification in the United States, has named Carrie Radabaugh, MPP, its Vice President, Governance and Board Relations.

Atrium Health, Wake Forest Baptist Health and Wake Forest University today announced the signing of a Memorandum of Understanding to create a next-generation academic healthcare system.

Point of Care Decision Support (PCDS), developer of an integrated electronic clinical decision support software for comprehensive individual patient care management and complex medication paradigms for patients with severe, chronic conditions; and CoaguSense, Inc., manufacturer of the world’s most precise portable PT/INR monitoring system using direct mechanical clot detection for patients on an anticoagulant therapy announce their strategic partnership.

Environmental Business Journal Recognizes Corporate Social Responsibility Innovations

Reflow Medical, Inc. has announced the completion of enrollment in its Wing-IT investigational device exemption trial, a prospective, multicenter, nonrandomized study evaluating the ability of the Wingman catheter to cross chronic total occlusions (CTOs) in peripheral lesions after failed guidewire attempts.

Dr. Melanie Altizer asked a co-worker how she was feeling one day – and never imagined such a simple question might save a life.

Eli Lilly and Company will announce its first-quarter 2019 financial results on Tuesday, April 30, 2019.

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company developing novel precision antibacterials to treat serious drug-resistant infections, today announced multiple data presentations on ETX2514SUL and ETX0282CPDP as well as its preclinical non-beta-lactam PBP inhibitor (NBP) program at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), taking place April 13-16, 2019 in Amsterdam, Netherlands.

Acreage Holdings (“Acreage”) (CSE: ACRG.U) (OTCQX: ACRGF), today announced the appointment of Corey Burchman, MD as Chief Medical Officer.